Articles From: Qualys Announces Fourth Quarter and Full Year 2012 Financial Results to Anacor Pharmaceuticals to Hold Conference Call Tomorrow, January 29, 2013 at 8AM ET to Discuss Preliminary Results from the First Phase 3 Study of Tavaborole for the Treatment of Onychomycosis

2012 Revenue Growth of 20% to $91.4 Million Fourth Quarter GAAP EPS of $0.03, Non-GAAP EPS of $0.06 Full Year 2012 GAAP EPS of $0.08, Non-GAAP EPS of $0.20 REDWOOD CITY, Calif., Feb.

http://media.marketwire.com/attachments/201211/53963_FMBIBW.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=988705&ProfileId=051205&sourceType=1 ITASCA, IL --

Third Quarter Results Driven By Domestic Theatrical Releases of THE TWILIGHT SAGA: BREAKING DAWN - PART 2 And Other Films As Well As Home Entertainment And International Operations Company Reports $125.2 Million In Free Cash Flow In The Third Quarter SANTA MONICA, Calif.

MILL VALLEY, Calif.

AUSTIN, Texas, Feb.

SAN FRANCISCO (MarketWatch) -- Shares of Hewlett-Packard Co.

GLENWOOD, Ill.

Halliburton (NYSE: HAL) will host a conference call on Monday, April 22, 2013, to discuss the first quarter 2013 financial results.

RockTenn (NYSE: RKT) announced today offers (each an “exchange offer” and collectively the “exchange offers”) to exchange all of its outstanding 4.450% Senior Notes due 2019 (the “Original 2019 Notes”) for its 4.450% Senior Notes due 2019, which have been registered under the Securities Act of 1933, as amended (the “Securities Act”) (the “Exchange 2019 Notes”), 3.500% Senior Notes due 2020 (the “Original 2020 Notes”) for its 3.500% Senior Notes due 2020, which have been registered under the Securities Act (the “Exchange 2020 Notes”), 4.900% Senior Notes due 2022 (the “Original 2022 Notes”) for its 4.900% Senior Notes due 2022, which have been registered under the Securities Act (the “Exchange 2022 Notes”) and 4.000% Senior Notes due 2023 (the “Original 2023 Notes” and, together with the Original 2019 Notes, the Original 2020 Notes and the Original 2022 Notes, the “Original Notes” and

Details Cost Synergies and Restructuring Charge in Connection with Recently Acquired Marvir Logistics BELLEVUE, Wash.

Wells Fargo & Company (NYSE:WFC) , one of America’s leading community banks; the City of Los Angeles; and NeighborWorks America, a national non-profit organization which creates opportunities for people to live in affordable homes and improve their lives, today celebrated the one-year anniversary of the NeighborhoodLIFT SM program by announcing 184 Angelenos have purchased a home through the initiative and $4.3 million of down payment assistance grants are still available for eligible home buyers who apply through Neighborhood Housing Services of Los Angeles County.

Aruba Networks, Inc. (NASDAQ:ARUN) today announced that Aruba Networks management will be presenting in the following events with the financial community.

The Central Europe and Russia Fund, Inc. (NYSE: CEE) (the “Fund” or “CEE”) announced the commencement of a self-tender offer on the terms and subject to the conditions set forth in the Fund’s Offer to Repurchase and the related Letter of Transmittal, which are being mailed to stockholders commencing today.

FORT LAUDERDALE, Fla., Feb.

MannKind Corporation (Nasdaq: MNKD) today reported financial results for the fourth quarter and year ended December 31, 2012.

Cardinal Bank (NASDAQ: CFNL) announced today that the Cardinal Bank Community Fund has awarded $12,500 to the Virginia Hospital Center Foundation .

RICHMOND, Va.

Universal Display Corporation (NASDAQ: PANL) , enabling energy-efficient displays and lighting with its UniversalPHOLED ® technology and materials, today announced that its results for the fourth quarter and full year 2012, ended December 31, 2012, will be released on Wednesday, February 27, 2013 after market close, at which time a copy of the financial results release will be available on the Company’s website at www.universaldisplay.com .

The Boards of Directors of Flaherty & Crumrine/Claymore Preferred Securities Income Fund Incorporated (NYSE: FFC) and Flaherty & Crumrine/Claymore Total Return Fund Incorporated (NYSE: FLC) today announced that each fund has approved (1) a change in its name and (2) the appointment of Destra Capital Investments LLC (“Destra Capital”) as its shareholder servicing agent effective on February 28, 2013.

Revenue Grows 31 Percent in Fiscal Year 2012; Reports 2012 GAAP diluted EPS of $0.84 and Non-GAAP diluted EPS of $1.40; Provides Strong Fiscal Year 2013 Outlook AMSTERDAM , Feb.

International Shipholding Corporation (NYSE: ISH) today announced the closing of its previously-announced sale of $25 million of its Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Shares”) at $100 per share.

Actian Corp.

Novatel Wireless, Inc. (NASDAQ: NVTL) , a leading provider of intelligent wireless solutions, announced preliminary financial results for the fourth quarter and fiscal year ended December 31, 2012.

Pervasive Software® Inc. (NASDAQ: PVSW) , a global leader in cloud-based and on-premises data innovation, today announced that it has entered into a definitive agreement to be acquired by an affiliate of Actian Corporation in a transaction with a total value of approximately $161.9 million.

http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0852390001&sourceType=1 http://media3.marketwire.com/docs/CASPIANenergylogoLARGE.png CALGARY, ALBERTA --

ATLANTA , Feb.

http://media.marketwire.com/attachments/201302/126426_WorldMotologoemail.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=984181&ProfileId=051205&sourceType=1 BANGKOK, THAILAND --

EQT Midstream Partners, LP (NYSE: EQM) , an EQT Corporation company, today announced the filing of its Annual Report on Form 10-K for the fiscal year ending December 31, 2012 with the Securities and Exchange Commission (SEC). The report is available on the EQT Midstream Partners (the Partnership) website at www.eqtmidstreampartners.com or on the SEC website at www.sec.gov .

Anacor Pharmaceuticals (NASDAQ:ANAC) will release preliminary results from the first of two Phase 3 studies of tavaborole for onychomycosis tomorrow, January 29, 2013 at approximately 7:00 a.m. ET.